First Registered Product Containing Setria Glutathione Approved in Chile

Kyowa Hakko announced that Setria Glutathione was featured in a product approved for sale in Chile through the Secretaría Regional Ministerial (SEREMI) de Salud. The supplement, developed by Nutrapharm, marks the first time a finished product containing Setria has received formal health authority approval in Chile. The Nutrapharm supplement features 500 mg of Setria Glutathione.

Setria is a patented, fermentation-derived form of reduced L-glutathione, featured in supplements in North America, Europe, Asia, and other regions, in products marketed for health categories including healthy aging, detoxification, women’s health, sports nutrition, and more.

“Chile’s supplement market continues to mature, with growing consumer interest in evidence-based products that are backed up with science,” said Gerardo Sanchez, CEO of Nutrapharm.

“Our use of clinically researched Setria and the approval by SEREMI validates our commitment to quality and transparency. This supplement offers meaningful benefits of modern life,” said Carmen Rodriguez, R&D director at Nutrapharm.